JP2021533090A5 - - Google Patents
Info
- Publication number
- JP2021533090A5 JP2021533090A5 JP2021500279A JP2021500279A JP2021533090A5 JP 2021533090 A5 JP2021533090 A5 JP 2021533090A5 JP 2021500279 A JP2021500279 A JP 2021500279A JP 2021500279 A JP2021500279 A JP 2021500279A JP 2021533090 A5 JP2021533090 A5 JP 2021533090A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- alkyl
- cancer
- composition according
- group
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1811364.7A GB201811364D0 (en) | 2018-07-11 | 2018-07-11 | Combination therapy |
| GB1811364.7 | 2018-07-11 | ||
| PCT/EP2019/068287 WO2020011724A1 (en) | 2018-07-11 | 2019-07-08 | Combination therapy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021533090A JP2021533090A (ja) | 2021-12-02 |
| JPWO2020011724A5 JPWO2020011724A5 (https=) | 2022-07-19 |
| JP2021533090A5 true JP2021533090A5 (https=) | 2022-07-19 |
Family
ID=63272970
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021500279A Pending JP2021533090A (ja) | 2018-07-11 | 2019-07-08 | 併用療法 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20230132256A1 (https=) |
| EP (1) | EP3820478A1 (https=) |
| JP (1) | JP2021533090A (https=) |
| KR (1) | KR20210031696A (https=) |
| CN (1) | CN112367999A (https=) |
| AU (1) | AU2019301850A1 (https=) |
| BR (1) | BR112021000456A2 (https=) |
| CA (1) | CA3101703A1 (https=) |
| EA (1) | EA202092824A1 (https=) |
| GB (1) | GB201811364D0 (https=) |
| IL (1) | IL279908A (https=) |
| MX (1) | MX2020013446A (https=) |
| PH (1) | PH12021550035A1 (https=) |
| SG (1) | SG11202012401RA (https=) |
| UA (1) | UA126313C2 (https=) |
| WO (1) | WO2020011724A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202011993D0 (en) | 2020-07-31 | 2020-09-16 | Adc Therapeutics Sa | ANTI-IL 13Ra2 antibodies |
| GB202015916D0 (en) * | 2020-10-07 | 2020-11-18 | Adc Therapeutics Sa | Combination therapy |
| WO2022248268A1 (en) * | 2021-05-28 | 2022-12-01 | Adc Therapeutics Sa | Combination therapy |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| HUT60768A (en) | 1990-03-16 | 1992-10-28 | Sandoz Ag | Process for producing cd25 fixing molecules |
| US7438907B2 (en) | 2002-11-15 | 2008-10-21 | Genmab A/S | Human monoclonal antibodies against CD25 |
| HRP20110498T1 (hr) | 2005-10-07 | 2011-08-31 | Exelixis | Azetidini kao inhibitori mek za liječenje proliferativnih bolesti |
| ES2653617T3 (es) * | 2011-02-02 | 2018-02-08 | Ashland Licensing And Intellectual Property, Llc | Recubrimiento de gel resistente al rayado |
| EP2906250B1 (en) * | 2012-10-12 | 2018-05-30 | ADC Therapeutics SA | Pyrrolobenzodiazepine-anti-psma antibody conjugates |
| AU2013328625B2 (en) * | 2012-10-12 | 2016-12-15 | Adc Therapeutics Sa | Pyrrolobenzodiazepine-antibody conjugates |
| AU2013328674B2 (en) * | 2012-10-12 | 2017-06-22 | Medimmune Limited | Pyrrolobenzodiazepines and conjugates thereof |
| AU2015352545B2 (en) | 2014-11-25 | 2020-10-15 | Adc Therapeutics Sa | Pyrrolobenzodiazepine-antibody conjugates |
| GB201506405D0 (en) | 2015-04-15 | 2015-05-27 | Berkel Patricius H C Van And Howard Philip W | Site-specific antibody-drug conjugates |
| GB201507827D0 (en) * | 2015-05-07 | 2015-06-17 | Adc Therapeutics Sarl | Diagnostic test |
-
2018
- 2018-07-11 GB GBGB1811364.7A patent/GB201811364D0/en not_active Ceased
-
2019
- 2019-07-08 AU AU2019301850A patent/AU2019301850A1/en not_active Abandoned
- 2019-07-08 UA UAA202008232A patent/UA126313C2/uk unknown
- 2019-07-08 WO PCT/EP2019/068287 patent/WO2020011724A1/en not_active Ceased
- 2019-07-08 BR BR112021000456-4A patent/BR112021000456A2/pt not_active Application Discontinuation
- 2019-07-08 JP JP2021500279A patent/JP2021533090A/ja active Pending
- 2019-07-08 EA EA202092824A patent/EA202092824A1/ru unknown
- 2019-07-08 KR KR1020217001943A patent/KR20210031696A/ko not_active Ceased
- 2019-07-08 CN CN201980045650.9A patent/CN112367999A/zh active Pending
- 2019-07-08 CA CA3101703A patent/CA3101703A1/en active Pending
- 2019-07-08 MX MX2020013446A patent/MX2020013446A/es unknown
- 2019-07-08 EP EP19742541.6A patent/EP3820478A1/en not_active Withdrawn
- 2019-07-08 SG SG11202012401RA patent/SG11202012401RA/en unknown
- 2019-07-08 US US17/259,466 patent/US20230132256A1/en not_active Abandoned
-
2020
- 2020-12-31 IL IL279908A patent/IL279908A/en unknown
-
2021
- 2021-01-06 PH PH12021550035A patent/PH12021550035A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021524449A5 (https=) | ||
| JP2019518741A5 (https=) | ||
| JP6215429B2 (ja) | Ｃｄ３８を特異的に認識する抗体とシクロホスファミドとを含有する抗腫瘍組合せ | |
| JP2018502902A5 (https=) | ||
| JP2020529863A5 (https=) | ||
| RU2019138337A (ru) | Конъюгаты на основе антитела, содержащие агонист toll-подобного рецептора, и виды комбинированной терапии | |
| JP2021523159A5 (https=) | ||
| HRP20171758T1 (hr) | Kombinacija dr5 agonista i anti-pd-1 antagonista i načini primjene | |
| JP2020527332A5 (https=) | ||
| JP2021533090A5 (https=) | ||
| JP2019501204A5 (https=) | ||
| JP2017502994A5 (https=) | ||
| ES2808565T3 (es) | Composiciones que comprenden anticuerpos anti-CD38 y carfilzomib | |
| JP2018534933A5 (https=) | ||
| JP2019506403A5 (https=) | ||
| JP2018516243A5 (https=) | ||
| JP6557744B2 (ja) | 抗腫瘍剤及び抗腫瘍効果増強剤 | |
| JP2017503000A5 (https=) | ||
| JP2015172049A (ja) | Ｃｄ３８を特異的に認識する抗体とビンクリスチンとを含有する抗腫瘍組合せ | |
| JP2020506951A5 (https=) | ||
| JP2017506234A5 (https=) | ||
| JP2018511628A5 (https=) | ||
| JP2021535110A5 (https=) | ||
| JPWO2019224275A5 (https=) | ||
| CN113597309B (zh) | 抗肿瘤组合物 |